Skip to main content
Top
Published in: World Journal of Surgery 4/2020

01-04-2020 | Gastrectomy | Original Scientific Report

Relationship Between the Waiting Times for Surgery and Survival in Patients with Gastric Cancer

Authors: Yuta Kumazu, Koji Oba, Tsutomu Hayashi, Takanobu Yamada, Kentaro Hara, Hiroaki Osakabe, Yota Shimoda, Masato Nakazono, Shinsuke Nagasawa, Yasushi Rino, Munetaka Masuda, Takashi Ogata, Takaki Yoshikawa, Takashi Oshima

Published in: World Journal of Surgery | Issue 4/2020

Login to get access

Abstract

Background

Surgery for gastric cancer should be performed as soon as possible after diagnosis. However, sometimes the waiting time for surgery tends to be longer. The relation between the waiting time for surgery and survival in patients with gastric cancer remains to be fully investigated.

Methods

This retrospective, single-center cohort study evaluated patients with gastric cancer who underwent curative surgery from 2006 through 2012 at Kanagawa Cancer Center in Japan. Patients who received neoadjuvant chemotherapy were excluded. The waiting time for surgery was defined as the time between the first visit and surgery. We investigated whether the waiting time for surgery has a linear negative impact on outcomes by using a Cox regression model with clinical prognostic factors.

Results

In total, 801 patients were eligible. The median waiting time was 45 days (range 10–269 days). The restricted cubic spline regression curve showed that the adjusted time-specific hazard ratios of waiting times did not indicate a linear negative trend on survival between 20 and 100 days (p = 0.759). In the Cox model with a quartile of waiting times, waiting times in the 32–44-day group, 43–62-day group, and ≥63 day groups were not associated with poorer overall survival as compared with the ≤31 day group (HR: 1.01, 95% CI 0.63–1.60, p = 0.984, HR: 1.17, 95% CI 0.70–1.94, p = 0.550, HR: 1.06, 95% CI 0.60–1.88, p = 0.831, respectively).

Conclusions

There was no negative relation between the waiting time for surgery (within 100 days) and survival in patients with gastric cancer.
Literature
1.
go back to reference Observatory TGC Cancer Today, World Health Organization (2019) Observatory TGC Cancer Today, World Health Organization (2019)
2.
go back to reference Association. JGc (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14:113–123CrossRef Association. JGc (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14:113–123CrossRef
3.
go back to reference Health Do Cancer Reform Strategy, UK, Department of Health, 2007 Health Do Cancer Reform Strategy, UK, Department of Health, 2007
4.
go back to reference Brenkman HJF, Visser E, van Rossum PSN et al (2017) Association between waiting time from diagnosis to treatment and survival in patients with curable gastric cancer: a population-based study in the Netherlands. Ann Surg Oncol 24:1761–1769CrossRef Brenkman HJF, Visser E, van Rossum PSN et al (2017) Association between waiting time from diagnosis to treatment and survival in patients with curable gastric cancer: a population-based study in the Netherlands. Ann Surg Oncol 24:1761–1769CrossRef
5.
go back to reference Ontario CC Target Wait Times for Cancer Surgery in Ontario, 2006 Ontario CC Target Wait Times for Cancer Surgery in Ontario, 2006
6.
go back to reference Sobin LHWC, Gospodarowicz M (2009) TNM classification of malignant tumors (UICC), 7th edn. Wiley, New York Sobin LHWC, Gospodarowicz M (2009) TNM classification of malignant tumors (UICC), 7th edn. Wiley, New York
7.
go back to reference Nakajima T (2002) Gastric cancer treatment guidelines in Japan. Gastric Cancer 5:1–5CrossRef Nakajima T (2002) Gastric cancer treatment guidelines in Japan. Gastric Cancer 5:1–5CrossRef
8.
go back to reference Bleicher RJ, Ruth K, Sigurdson ER et al (2016) Time to surgery and breast cancer survival in the United States. JAMA Oncol 2:330–339CrossRef Bleicher RJ, Ruth K, Sigurdson ER et al (2016) Time to surgery and breast cancer survival in the United States. JAMA Oncol 2:330–339CrossRef
9.
go back to reference Coughlin S, Plourde M, Guidolin K et al (2015) Is it safe to wait? The effect of surgical wait time on survival in patients with non-small cell lung cancer. Can J Surg 58:414–418CrossRef Coughlin S, Plourde M, Guidolin K et al (2015) Is it safe to wait? The effect of surgical wait time on survival in patients with non-small cell lung cancer. Can J Surg 58:414–418CrossRef
10.
go back to reference Elit LM, O’Leary EM, Pond GR et al (2014) Impact of wait times on survival for women with uterine cancer. J Clin Oncol 32:27–33CrossRef Elit LM, O’Leary EM, Pond GR et al (2014) Impact of wait times on survival for women with uterine cancer. J Clin Oncol 32:27–33CrossRef
11.
go back to reference Flemming JA, Nanji S, Wei X et al (2017) Association between the time to surgery and survival among patients with colon cancer: a population-based study. Eur J Surg Oncol 43:1447–1455CrossRef Flemming JA, Nanji S, Wei X et al (2017) Association between the time to surgery and survival among patients with colon cancer: a population-based study. Eur J Surg Oncol 43:1447–1455CrossRef
12.
go back to reference van Harten MC, Hoebers FJ, Kross KW et al (2015) Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol 51:272–278CrossRef van Harten MC, Hoebers FJ, Kross KW et al (2015) Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol 51:272–278CrossRef
13.
go back to reference Visser E, Leeftink AG, van Rossum PS et al (2016) Waiting time from diagnosis to treatment has no impact on survival in patients with esophageal cancer. Ann Surg Oncol 23:2679–2689CrossRef Visser E, Leeftink AG, van Rossum PS et al (2016) Waiting time from diagnosis to treatment has no impact on survival in patients with esophageal cancer. Ann Surg Oncol 23:2679–2689CrossRef
14.
go back to reference Neal RD, Tharmanathan P, France B et al (2015) Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 112(Suppl 1):S92–107CrossRef Neal RD, Tharmanathan P, France B et al (2015) Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 112(Suppl 1):S92–107CrossRef
15.
go back to reference Yun YH, Kim YA, Min YH et al (2012) The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol 23:2731–2737CrossRef Yun YH, Kim YA, Min YH et al (2012) The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol 23:2731–2737CrossRef
16.
go back to reference Tsukuma H, Oshima A, Narahara H et al (2000) Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut 47:618–621CrossRef Tsukuma H, Oshima A, Narahara H et al (2000) Natural history of early gastric cancer: a non-concurrent, long term, follow up study. Gut 47:618–621CrossRef
Metadata
Title
Relationship Between the Waiting Times for Surgery and Survival in Patients with Gastric Cancer
Authors
Yuta Kumazu
Koji Oba
Tsutomu Hayashi
Takanobu Yamada
Kentaro Hara
Hiroaki Osakabe
Yota Shimoda
Masato Nakazono
Shinsuke Nagasawa
Yasushi Rino
Munetaka Masuda
Takashi Ogata
Takaki Yoshikawa
Takashi Oshima
Publication date
01-04-2020
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 4/2020
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05367-8

Other articles of this Issue 4/2020

World Journal of Surgery 4/2020 Go to the issue